health care middle east and north africa - … care middle east and north africa ... saudi arabia...
TRANSCRIPT
Explore a tangible roadmap towards achieving a truly world-class health care system in the Middle East and North Africa
www.hcmena.economist.com
Gold Sponsors Exhibitor sponsor Official PR Agency
Research Based Pharmaceutical Companies Committee in Saudi
PhRMAGPharmaceutical Research &Manufacturers Association Gulf
HEALTH CARE MIDDLE EAST AND NORTH AFRICAInnovation powering health-care delivery
October 13th 2015, Madinat Jumeirah, Mina A’Salam, Dubai
Join the conversation@EconomistEvents#hcmena
Knowledge partnerSilver sponsor
www.hcmena.economist.com
ABOUT THE SUMMITHow can the Middle East and North Africa deliver a truly world-class health-care system?The MENA region has faced a surge in demand for health care services in recent years. Shifting socio-economic factors such as increased income and better access to modern amenities have led to widespread lifestyle changes, fuelling a rise in lifestyle-related illnesses such as cancer, obesity, diabetes and heart disease.
According to the World Health Organisation (WHO), non-communicable diseases will account for nearly 60% of the region’s disease burden in the next five years. The International Diabetes Federation (IDF) estimates that one in 10 adults in the Middle East region currently suffers from diabetes. It forecasts that this figure will more than double over the next twenty years, reaching 68 million, or 25% of the estimated population by 2035.
Join us as we bring together decision makers from the public and private sectors to explore how can the Middle East & North Africa deliver a truly world-class health care system:• Hear from national and international policy makers representing the World Health Organisation, Ministry of
Education Bahrain and International Diabetes Federation.
• Gain new perspectives on the future of health-care systems in the region; discuss policy, trends, tackling the talent crisis, international benchmarking and technological innovation.
• Network with influential health-care stakeholders that include government, pharmaceutical, biotech, healthcare providers, suppliers, patient groups and NGOs.
HEALTH CARE MIDDLE EAST SUMMIT 2014 STATISTICS
182 attendees
100% of our audience would recommend our event to colleagues
17
Group discounts are available for groups of 3 or more delegates.
Please email the team on [email protected] or call +44 (0) 207 576 8118 for further details
62% of the audience were
director level or above
countries represented
Supporting organisations Supported by Supporting publications
PROGRAMME
Excellently planned and managed event. Managing Director DNA Health Corp
8.15 Registration
09.15 OPENING REMARKS FROM THE CHAIRDr Vivek Muthu, Chief Health Advisor, Economist Intelligence Unit Healthcare, United Kingdom
09.30 KEYNOTE ADDRESS: DRIVING GROWTH AND COMPETITIVENESS IN THE HEALTH CARE SECTORHE Dr Amin Al-Amiri, Assistant Undersecretary, Ministry of Health, United Arab Emirates
10.00 KEYNOTE ADDRESS: HEALTH CARE SECTOR INNOVATION: ECONOMIC DIVERSIFICATION AND ACHIEVING A KNOWLEDGE-BASED ECONOMY HE Hani Al-Hamli, Secretary General, Dubai Economic Council, United Arab Emirates
10.30 PANEL DISCUSSION: HEALTH CARE POLICY AND THE ROLE OF INDUSTRY: ALIGNING PUBLIC AND PRIVATE SECTOR OBJECTIVES TO DRIVE INNOVATION IN HEALTH CARE DELIVERYAccording to WHO statistics, the GCC has one of the highest incidences of NCDs in the world. A vast youth demographic and a rapidly ageing population, paired with vast socio-economic disparity across the region resulting in varying rates of access to health care facilities and treatments, regional governments are facing significant challenges to ensure health systems are robust, sustainable and provide quality, affordable care to all. The GCC pricing harmonisation policy, enacted throughout 2014, has been a strategic attempt to regulate pricing and improve access to medicines. However, there is debate around the efficacy of this policy many argue that price restrictions are hindering innovation and ultimately, adversely affecting patient health as well as sector growth. This session will bring together key stakeholders from government and the private sector to talk about the strategic policies guiding the future of health care in the region, identifying the main challenges to implementation, and what tangible KPIs need to be put in place to ensure a collaborative approach to foster innovation and deliver world-class health care throughout the Middle East.
Marwan Abdulaziz Executive Director, DuBiotech, United Arab Emirates Dr Petra Wilson, Chief Executive Officer, International Diabetes Federation, Belgium Dr Sameen Siddiqi, Director, Department of Health Systems Development, World Health Organization, Eastern Mediterranean Regional Office (WHO EMRO), EgyptSamir A. Khalil, PhRMA, United Arab Emirates
11.20 MORNING REFRESHMENTS AND NETWORKING BREAK
11.50 PANEL DISCUSSION: EVOLVING HEALTH CARE TRENDS: IMPROVING ACCESSIBILITY, EFFICIENCY AND EFFECTIVENESSThis session will provide a platform for discussion around evolving health care trends across the MENA region, including feedback on initiatives empowering primary care physicians and the growing scope of primary care centres. It will examine the role of community-centred care and ‘accessible cities’ outpatient facilities for more efficient, and accessible, treatment options for chronic illnesses, rehabilitative care, geriatric as well as examine the issue of patient accountability. It will also evaluate regional initiatives to improve affordability and access to care such as compulsory insurance regulations, providing feedback on how these programmes are rolling out and lessons learned from a year in review as well as a discussion around how innovation is improving efficiency and effectiveness in health care delivery.
Dr A Abyad, Chief Executive Officer, Abyad Medical Center, LebanonDr Mahiben Maruthappu, Co-founder, NHS Innovator Accelerator, United Kingdom Arjen Radder, Chief Executive Officer, Philips, Middle East & Turkey Hisham Radwan, Vice-president, Regional General Manager – MEA, Aetna International, United Arab Emirates
Tuesday October 13th 2015
12.40 INTERNATIONAL BENCHMARKING: HOW IS SINGAPORE DRIVING INNOVATION AND VALUE-GENERATION IN BIOMEDICAL R&D?Over the past twenty years, Singapore has made a concerted effort to establish itself as a global leader in biomedical R&D. This session will provide a model demonstrating the link between health care investment in R&D, skills training, manufacturing and innovation resulting in Singapore’s current position as a world-leading health care hub.
Dr Benjamin Seet, Executive Director, Biomedical Research Council, Singapore
13.15 LUNCH
14.20 TACKLING THE TALENT CRISIS: EDUCATION AND SKILLS TRAINING FOR A SUSTAINABLE HEALTH CARE SYSTEMThe Middle East is facing a severe shortage of skilled medical talent. With the major push to increase capacity in recent years leading to an ever-growing number of health care facilities, and increased demand from a growing population burdened with high rates of NCDs, the pressure is on to source qualified medical professionals. In the GCC, it is estimated that over 80% of physicians and nurses are expats. Authorities are faced with the task of encouraging MENA nationals to take roles in the burgeoning health care sector, whilst also ensuring the educational framework is in place to support further skills development. This session will explore what is being done to address the talent shortage in the health care sector and what measures need to be put in place to ensure a sustainable resource infrastructure going forward.
Cameron Mirza, Head of Projects and Strategy, Secretariat-General of the Higher Education Council, Ministry of Education, Bahrain Dr Javaid I. Sheikh, Dean, Weill Cornell Medical College, QatarDr Mussaad al-Razouki, Chief Business Development Officer, Kuwait Life Sciences Company, KuwaitDr Sulaiman al-Emran, Deputy Secretary General, Saudi Commission for Health Specialties, Saudi Arabia
15.10 PANEL DISCUSSION: TECHNOLOGICAL INNOVATION AND QUALITY OF CAREPatient safety, resource efficiency, affordability and accessibility are all key considerations when evaluating quality of care outcomes. Advancements in medical technologies and ICT mean that health care systems and providers are better able to treat and care for patients, with the added benefit of improving efficiencies and reducing costs. This session will delve into the role of innovation in how we collect, manage and analyse patient data, as well as evaluate the latest technological innovations allowing for more affordable, higher quality care in the MENA region.
•How is technology improving patient-centricity and patient outcomes?
•What role does technological innovation play in attracting private investment into the health care sector?
Dr Bern Shen, Chief Medical Officer, HealthCrowd, United Arab EmiratesGareth Sherlock, Chief Information Officer, Cleveland Clinic Abu Dhabi, United Arab EmiratesDr Helmut M. Schühsler, Chairman and Chief Executive Officer, TVM Capital Healthcare Partners, United Arab EmiratesDr Mohammad al-Redha, Director, Health Data and Information Analysis Department, Dubai Health Authority, United Arab Emirates
16.00 CLOSING KEYNOTE: THE FUTURE OF HEALTH CARE: FOCUS ON THE PATIENT EXPERIENCE Hear from this world-leader in health care on the trends and innovations that are best serving patients.
Dr David Hayes, Medical Director, Mayo Clinic Care Network and International Relations, Mayo Clinic, United States
16.30 CLOSING REMARKS AND END OF CONFERENCE
It brought stakeholders from all walks of life/business togetherDirector UNAIDS
CONFIRMED SPEAKERS INCLUDE:
MARWAN ABDULAZIZ Executive Director DuBiotech United Arab Emirates
DR SULAIMAN EL-EMRAN Deputy Secretary General Saudi Commission for Health Specialties Saudi Arabia
DR A ABYAD Chief Executive Officer Abyad Medical Center Lebanon
SAMIR A. KHALIL Executive Director, Middle East & Africa PhRMA United Arab Emirates
DR BENJAMIN SEETExecutive Director Biomedical Research Council Singapore
CAMERON MIRZA Head of Projects and Strategy Secretariat-General of the Higher Education Council, Ministry of Education Bahrain
HISHAM RADWAN, Vice-president, Regional General Manager – MEA Aetna International United Arab Emirates
DR SAMEEN SIDDIQI Director, Department of Health Systems Development World Health Organization, Eastern Mediterranean Regional Office (WHO EMRO) Egypt
DR DAVID HAYES Medical Director Mayo Clinic Care Network and International Relations Mayo Clinic United States
DR MOHAMMAD AL-REDHA Director, Health Data and Information Analysis Department Dubai Health Authority United Arab Emirates
DR JAVAID I. SHEIKH Dean Weill Cornell Medical College Qatar
BERN SHEN Chief Medical Officer HealthCrowd United Arab Emirates
Sponsorship opportunities are available. Please contact Kay Westmoreland on +971 4433 4208 or email [email protected].
DR PETRA WILSON Chief Executive Officer International Diabetes Federation Belgium
GARETH SHERLOCK Chief Information Officer Cleveland Clinic Abu Dhabi United Arab Emirates
DR VIVEK MUTHU Chief Health Advisor Economist Intelligence Unit Healthcare United Kingdom
2014 ATTENDING COMPANIES INCLUDED: • 7 Days• Abbott Laboratories• AbbVie BioPharmaceuticals GmBH• ABC Dubai• Abu Dhabi National Insurance
Company• Aegis Capital• Aetna• Al Mariya Polyclinic• Al Noor Hospital• AlSharq Health Care Member of
Fujairah• National Group• American Hospital• Anglo Arabian Healthcare• Arya Insurance Brokerage
Company• AstraZeneca• Atlas Medical Technologies• Axa Insurance• Bait Al Batterjee Holding Company• Bayer Healthcare• Bennett Jones• BeUtiful You• BLI• Boehringer Ingelheim• Bristol-Myers Squibb• Burjeel Hospital• CAIN• ClinArt International• Clinart MENA• Dar Al Khaleej• DNA Health Corp• Dubai Eye 103.8• Dubai Health Authority• DuBiotech
• Economist Intelligence Unit• Edelman• Eli Lilly and Company• Emmahim Global Network Link• Falcon and Associates• GE Healthcare• Grayling• GSK• Gulf News• Health Authority of Abu Dhabi• Health Beyond Borders• Healthcare Industry Service Center• Hoffmann-La Roche Ltd• ICME International• Janssen Gulf• Johns Hopkins Aramco Healthcare• Joint Commission International• Julphar• KARL STORZ - ENDOSKOPE East
Mediterranean Gulf• King Hussein Cancer Foundation• King Saud bin Abdulaziz University• Kleos Healthcare Corporation• Kuwait News Agency (KUNA)• Leo Pharma• Les Laboratoires Servier - Gulf
Region• Lux Actuaries and Consultants• Mafraq Hospital- SEHA• Manchester Clinic Jumeriah• MD Lifeline Hospital• MedDrop GmbH• Mediclinic City Hospital Dubai• MEED• Menasa and Partners• Merck Sharp & Dohme
• Middle East Health Magazine• Moorland Gray Executive Search• Mundipharma• NGC Medical• NMC Healthcare• Novartis• Now Health International• Oracle Middle East and North
Africa• Pfizer• Pharmax Pharmaceuticals FZ• Philips• PhRMAG• Prime Minister’s Office, UAE• Quanteus• RAK Hospital• Sanofi• Saudi Aramco• Shane Phillips Consultants• Sheikh Khalifa Medical City• Siegel+Gale• Spengler Fox• Supreme Council of Health• Taha Actuaries & Consultants• Takeda• Tawam Hospital• TECOM Investments• The Gulf Today• The National• Thomson Reuters• U N CARGO & LOGISTIC• Vision Executive Search• vps healthcare
DELEGATE DETAILS
First Name (Dr/Mr/Mrs/Ms) Surname
Job Title Industry Sector
Company
Address
Town/city Postcode Country
Tel Fax Email
HOW TO REGISTER
ONLINE www.hcmena.economist.com
EMAIL [email protected]
CALL US +44 (0) 20 7576 8118
FAX +44 (0) 20 7576 8472
POST The Economist Events, Customer Service EMEA, 20 Cabot Square, Canary Wharf, London E14 4QW, UK
DATA PROTECTION
The Economist Events is part of The Economist Group. Occasionally, the companies in The Economist Group would like to contact you about new features, events, news, special offers and for market research purposes.
Tick this box if you’d like to hear from us by e-mailWe’ll assume that we may contact you unless you tick these boxes:
No contact from us by post No contact from us by telephone
No contact from other selected companies about their products and services by post
The Economist Group is a global organisation and operates a strict privacy policy around the world. To read more about us and our privacy policy please go to www.economistgroup.com/privacy
TERMS AND CONDITIONS
Your delegate fee should be paid in full prior to attendance. If payment has not been received you will not be permitted to enter the event. Cancellations: Should you not be able to attend the event, substitutions can be made at no extra charge up until the event. If a suitable replacement cannot be found, then an administration fee of 20% will be incurred for cancellations received more than 21 days prior to an event. When a cancellation is made less than 21 days prior to an event, the registered delegate is liable for full payment of the fee. Economist Events reserve the right to change the programme if necessary.
Discounts are available for groups of 3 or more delegates.
Please email the team on [email protected] or call +44 (0) 207 576 8118 for further details
CONFIRMATION
I confirm that I have read and accepted The Economist Events’ terms and
conditions policy and I am authorised to sign this document on behalf of the
above company.
Signature: Date:
Payment methods (delegates fee(s) strictly payable in advance)
Credit Card (tick as appropriate): Amex Visa Mastercard Name as it appears on card: Card No. Expiry date: / 3/4 digital security number:
Bank transfer Payable to Barclays Bank Plc, please quote ref: EM1342 and send a copy of the instructions together with your registration form. Account Name: The Economist Intelligence Unit. Account Number:54609155, Sort Code: 20-67-59. IBAN: GB09BARC20675954609155 Swift address: BARCGB22
We require an invoice to raise payment (Bookings with requests for bank tranfsers and invoices should be received before September 12th 2015.) Please complete below if the billing contact is not the registered delegate.
Billing contact: PO number (if required):
Billing address (if different from the Organisation address):
HEALTH CARE MIDDLE EAST AND NORTH AFRICAOctober 13th 2015 - Madinat Jumeirah, Mina A’Salam Hotel, Dubai, UAE
DELEGATE FEES (PER PERSON)
Category Standard Rate Quantity Total
Pharmaceutical & Biotech Companies $900.00
Health Care Providers $675.00
Subscribers to The Economist $720.00
Gov/NGOs/public sector $540.00
Total
WEB